×

img Acces sibility Controls

Research Projects Banner

Research Projects

Ruthenium(II)-Catalyzed Dual C-H bond Activation and Oxidative Annulation for Regioselective synthesis of Novel Functionalized Heterocycles

Implementing Organization

Thapar Institute of Engineering & Technology
Principal Investigator
Dr. Kamaldeep Paul
Thapar Institute of Engineering & Technology

Project Overview

Heterocycles are crucial in supramolecular and medicinal chemistry, with a wide range of materials and drug molecules having nitrogen-containing heterocyclic scaffolds. The development of novel methods for designing and synthesizing these nitrogen-containing heterocycles is abundant, with the formation of C-C bonds often beyond the imagination of synthetic chemists. To demonstrate the accessibility of this approach, an investigation was conducted to develop divergent C-H functionalization reactions of un-activated C-H bonds. This direct functionalization of un-activated C-H bonds continues to challenge chemists and inspire new chemistry. The proposal aims to use the fascinating chemistry of double C-H activation and oxidative annulation to fashion a route to diverse heterocyclic scaffolds, including scaffolds such as imidazo[1,2-a]chromeno[3,4-c]pyridine, chromeno[3',4':3,4]pyrido[2,1-b]quinazoline, 1H-phenanthro[9,10-d]imidazole, and biological active moieties like rutaecarpine and benzo[c][1,2]diazepine analogs. The scientific objectives of the proposal include synthesizing new coumarin and quinazoline-based analogs by double C-H bond functionalization and annulation reaction derived from simple conjugates, gaining deeper insight into the aza-Michael reaction and mechanistic aspects of alkenylation/alkylation followed by cyclization, exploring substitutions and time-dependent reactivity switch to access novel 1H-phenanthro[9,10-d]imidazole and related compounds, conducting photophysical studies to explore their fluorescent properties, synthesizing biological active rutaecarpine and benzo[c][1,2]diazepine analogues, and accessing novel quinoxaline-2(1H)-one analogs and their further transformations to industrial relevant applications.
Funding Organization
Funding Organization
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Chemical Sciences
Start Year
2024
End Year
2027
Sanction Amount
₹ 33.74 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop